Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.23.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Grant revenue $ 13,163 $ 30,391 $ 30,187 $ 45,474
Operating expenses:        
Research and development 2,006,696 2,590,032 3,679,272 5,883,693
General and administrative 1,115,785 1,044,334 2,365,048 2,375,883
Local business tax 490 980
Total operating expenses 3,122,481 3,634,856 6,044,320 8,260,556
Loss from operations (3,109,318) (3,604,465) (6,014,133) (8,215,082)
Other income (expense):        
Interest income 58,954 15,369 121,155 27,275
Interest expense (843) (816) (4,190) (4,062)
Miscellaneous income 621 369 1,745 11,333
Total other income, net 58,732 14,922 118,710 34,546
Loss before income taxes (3,050,586) (3,589,543) (5,895,423) (8,180,536)
Income tax benefit
Net loss $ (3,050,586) $ (3,589,543) $ (5,895,423) $ (8,180,536)
Basic net loss per share $ (1.51) $ (1.85) $ (2.91) $ (4.22)
Diluted net loss per share $ (1.51) $ (1.85) $ (2.91) $ (4.22)
Shares used to compute basic net loss per share 2,024,766 1,939,913 2,024,766 1,939,913
Shares used to compute diluted net loss per share 2,024,766 1,939,913 2,024,766 1,939,913